Advertisement

Topics

FDA approves Pfizer's drug for rare blood cancer

10:28 EDT 17 Aug 2017 | Reuters

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's rare blood cancer drug, Besponsa, with a boxed warning.

Original Article: FDA approves Pfizer's drug for rare blood cancer

NEXT ARTICLE

More From BioPortfolio on "FDA approves Pfizer's drug for rare blood cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pfizer
Pfizer is a global pharmaceutical company, the largest in world based on annual sales.  In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...